HilleVax (HLVX)
(Real Time Quote from BATS)
$1.88 USD
+0.04 (2.17%)
Updated Jul 25, 2024 03:52 PM ET
After-Market: $1.89 +0.01 (0.53%) 4:18 PM ET
2-Buy of 5 2
D Value D Growth B Momentum D VGM
Brokerage Reports
0 items in cart
HilleVax, Inc. [HLVX]
Reports for Purchase
Showing records 1 - 4 ( 4 total )
Company: HilleVax, Inc.
Industry: Medical - Biomedical and Genetics
Phase 2B NEST-IN1 Topline Mid-2024 - To Define HIL-214 Path For Infants and Adults; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CAUFIELD M
Company: HilleVax, Inc.
Industry: Medical - Biomedical and Genetics
HIL-214 Progress - Thoughts on NEST-IN1 Phase 2B Topline Expected Mid-2024; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CAUFIELD M
Company: HilleVax, Inc.
Industry: Medical - Biomedical and Genetics
HLVX Company Report ; Initiation of Coverage
Provider: H.C. Wainwright & Co., Inc.
Analyst: CAUFIELD M
Company: HilleVax, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for HLVX 112123
Provider: Stock Traders Daily
Analyst: Research Department
|